A New Potential Therapeutic Target for Alzheimer’s Disease
August 4, 2026
Welcome to Greg Rowland’s Alzheimer’s Research Report.
Each report now begins with a brief summary, allowing you to instantly assess its relevance, grasp the core insights, and decide if the full piece warrants a deeper dive.
Due to the significant amount of research and writing to bring each report to life, this is a subscription-only publication. We offer three ways to stay informed:
Monthly Subscription: $10 per month
Annual Subscription: $100 per year (Save $20 annually)
Founder’s Circle: $250 per year (Includes an exclusive monthly video conference to discuss emerging Alzheimer’s treatments in close detail)
I believe the value of a full month of my research reports matches (or exceeds!) the value of a single coffee and muffin. Please consider subscribing so this publication is sustainable. Thank you!
SUMMARY
A University of Minnesota research team has identified a type of plaque that represents a new potential therapeutic target for Alzheimer’s disease.
